← Back to Search

Catheterization

ECG-Guided Umbilical Vessel Catheterization for Acute Lymphoblastic Leukemia

N/A

Recruiting

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of ecg placement and reading (typically 15 minutes)

Awards & highlights

Study Summary

This trial is testing whether a more non-invasive means of placing and continuously monitoring an umbilical venous catheter, using superficial electrocardiogram (ECG) tracings, is better than the current method.

Who is the study for?

This trial is for newborn pediatric patients who weigh between 2 to 6 kilograms and either require or currently have an umbilical venous catheter (UVC). To participate, they must have consent from parents. Clinically unstable infants cannot take part in this study.Check my eligibility

What is being tested?

The study is testing the use of electrocardiogram (ECG) monitoring as a non-invasive method to place and continuously monitor the position of UVCs in neonates, aiming to reduce misplacement risks associated with traditional methods.See study design

What are the potential side effects?

Since ECG is a non-invasive monitoring technique, it's generally safe. However, there may be minimal risks related to skin irritation from electrode placement or potential discomfort during the procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of ecg placement and reading (typically 15 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of ecg placement and reading (typically 15 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of ecg placement and reading (typically 15 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Electrocardiogram Readings

Trial Design

1Treatment groups

Experimental Treatment

Group I: ECG MonitoringExperimental Treatment1 Intervention

ECG readings will be collected for neonatal patients who require or currently have UVC

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ECG

2016

Completed Phase 4

~33710

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,445 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment seeking participants who are 18 years or older?

"Participants in this medical experiment need to be over 1-year old but below 45 years of age."

Answered by AI

What is the capacity of people invited to partake in this trial?

"Affirmative. The clinicaltrials.gov site shows that this trial is actively seeking participants, which was first posted on August 25th 2020 and revised on June 10th 2022. 150 volunteers are needed from a single centre to participate in the study."

Answered by AI

Who qualifies to partake in this medical study?

"This medical trial requires 150 pediatric patients aged 1 day to 45 days, weighing between 2 and 6 kgs. Those who are eligible must either require or currently have UVC support."

Answered by AI

Is enrollment open for this particular clinical investigation?

"Per the clinicaltrials.gov listing, this medical trial is still accepting volunteers who meet its inclusion criteria. The research project was initially posted on August 25th 2020 and most recently updated June 10th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Umbilical Vessel Catheterization Under ECG Monitoring and Guidance

Chi-Ho Ban Tsui 2020. "Umbilical Vessel Catheterization Under ECG Monitoring and Guidance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03898596.